Feifei Ma
Impact in
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 6
- Protease and Inhibitor Mechanisms 3
Feifei Ma
45 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 106
- Neurology 210
- Cancer Research 297
- Molecular Biology 621
- Cardiology and Cardiovascular Medicine 197
- Immunology 114
Countries citing papers authored by Feifei Ma
This map shows the geographic impact of Feifei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Ma more than expected).
Fields of papers citing papers by Feifei Ma
This network shows the impact of papers produced by Feifei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Ma. The network helps show where Feifei Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feifei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2021 | 18 | |
| 12 | 2021 | 4 | |
| 13 | 2019 | 63 | |
| 14 | 2017 | 27 | |
| 15 | 2017 | 6 | |
| 16 | 2016 | 23 | |
| 17 | 2015 | 42 | |
| 18 | 2014 | 3 | |
| 19 | Effects of Herba Gentianellac on Rheumatoid Arthritis and its Mechanism | 2011 | 1 |
| 20 | 2011 | 38 |
About Feifei Ma
Feifei Ma is a scholar working on Cancer Research, Neurology, Pharmacology, Molecular Biology and Neurology, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (6 papers), RNA modifications and cancer (4 papers), Acute Ischemic Stroke Management (4 papers), Circular RNAs in diseases (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Neurology (210 citations), Cancer Research (297 citations), Molecular Biology (621 citations), Cardiology and Cardiovascular Medicine (197 citations) and Immunology (114 citations). Feifei Ma has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Ke‐Jie Yin, Shengrong Ouyang, Xuejing Zhang, Jianxin Wu, Hui‐Hua Li, Jie Du, Yulin Li, Lixin Jia, Yongfen Qi and Jizhong Cheng. Their work appears in journals such as Journal of Cerebral Blood Flow & Metabolism, Nutrition & Metabolism, International Journal of Molecular Sciences, Journal of Enzyme Inhibition and Medicinal Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.